Elucidation of molecular mechanisms of neurodegenerative diseases caused by expansion of CAG repeats

阐明CAG重复序列扩增引起的神经退行性疾病的分子机制

基本信息

  • 批准号:
    12307014
  • 负责人:
  • 金额:
    $ 22.39万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

This study was aimed to elucidate molecular mechanisms ofheurodegetterative diseases caused by expansion of CAG repeats. To accomplish this aim, two strategies! have been employed; 1. Molecular cloning of CAG repeat-containing cDNAs expressed in human brains as the candidate genes for hereditary neurodegenerative diseases, and 2. Elucidation of mechanisms of neurodegeherati6n : caused by expahded; CAG repeats coding for polyglutarnine stretches. As the former approach, we screened human brain cDNA libraries using (CAG)10 or (CAG)20 oligbnucleotide probes. Excluding overlapping clones, we have identified 92 independent cDNA clones as the CAG repeat-containing CDNA clones. Among the 92 clones, we selected 41 clones as the CDNA clones carrying > 10 CAG repeats. These cDNA clones are beihg screeried as the candfdate genes for hereditary neurddegenerative disease. As the latter approach, we focused our study to elucidate the mechanisms of nuclear dysfunctions as a result of nuclear transport and intranuclear accumulation of mutant protein carrying expanded polyglutamine stretches. We performed expression pro filing of Q129 mice catfying a full-length mutant DRPEA gene carrying a largely expanded GAG repeat (129 repeat units) that have been developed in our laboratory. Detailed expression pro filing analysis revealed 78 down-regulated genes and 16 up-regulated genes. The alteration of expression levels is observed as a time-dependent manner. Many cAMP-resporisive genes were included in the dpwh-regulated genes, confirming our hypothesis that CREB-dependent transcriptional activation is suppressed by expanded polyglutamine stretches.
本研究旨在阐明CAG重复序列扩增引起神经退行性疾病的分子机制。为了实现这一目标,两个战略!已就业; 1。人脑中表达的CAG重复序列cDNA的分子克隆,作为遗传性神经退行性疾病的候选基因。神经脱髓鞘机制的阐明:由编码多聚谷氨酰胺延伸的CAG重复序列引起。作为前一种方法,我们用(CAG)10或(CAG)20寡核苷酸探针筛选人脑cDNA文库。排除重叠克隆,我们已经确定了92个独立的cDNA克隆作为CAG重复序列的cDNA克隆。在92个克隆中,我们选择了41个克隆作为携带> 10个CAG重复的cDNA克隆。这些cDNA克隆被认为是遗传性神经退行性疾病的候选基因。作为后一种方法,我们的研究重点是阐明核功能障碍的机制,作为核运输和核内积累的突变蛋白携带扩大聚谷氨酰胺延伸的结果。我们对携带全长突变DRPEA基因的Q129小鼠进行了表达谱分析,该基因携带我们实验室开发的大幅扩展的GAG重复序列(129个重复单位)。详细的表达谱分析显示78个基因表达下调,16个基因表达上调。以时间依赖性方式观察表达水平的改变。许多cAMP反应基因被包括在dpwh调控基因中,证实了我们的假设,即CREB依赖的转录激活被扩展的多聚谷氨酰胺片段抑制。

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shimohata, T: "Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation:; in polyglutamine diseases."Neuropathology. 20. 326-333 (2000)
Shimohata,T:“扩展的多聚谷氨酰胺片段与核转录因子的相互作用导致异常的转录调节:在多聚谷氨酰胺疾病中。”神经病理学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakamura, K: "SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein"Human Molecular Genetics. 10(14). 1441-1448 (2001)
Nakamura, K:“SCA17,一种新型常染色体显性小脑共济失调,由 TATA 结合蛋白中扩展的聚谷氨酰胺引起”人类分子遗传学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Gaspar, C: "Ancestral origins of the Machado-Joseph disease mutation : A Worldwide haplotype study."Am. J. Hum. Genet.. 68・2. 523-528 (2001)
Gaspar, C:“马查多-约瑟夫病突变的祖先起源:全球单倍型研究。”Am. 523-528。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakamura, K: "SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein."Human Molecular Genetics. 10・14. 1441-1448 (2001)
Nakamura, K:“SCA17,一种由 TATA 结合蛋白中扩展的聚谷氨酰胺引起的新型常染色体显性小脑共济失调。”人类分子遗传学 10・14(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamada, M: "Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases."American Journal of Pathology. 159・5. 1785-1795 (2001)
Yamada, M:“CAG 重复疾病中神经元核内包涵体与早幼粒细胞白血病蛋白核和卷曲体之间的相互作用。”美国病理学杂志 159・5(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUJI Shoji其他文献

TSUJI Shoji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUJI Shoji', 18)}}的其他基金

Etiology of minimal change nephrotic syndrome focusing on the gut microbiota affecting gut immunity.
微小病变肾病综合征的病因学重点关注影响肠道免疫的肠道微生物群。
  • 批准号:
    19K08287
  • 财政年份:
    2019
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of molecular basis and therapeutic strategy of immune-mediated neurological diseases based on comprehensive analysis of autoantibodies
基于自身抗体综合分析阐明免疫介导的神经系统疾病的分子基础和治疗策略
  • 批准号:
    23249048
  • 财政年份:
    2011
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
On the General study by the time studies about the gap between hight speed and the human rhythm in the modern society
论现代社会高速运动与人类节奏差距的时间研究
  • 批准号:
    21310108
  • 财政年份:
    2009
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a comprehensive molecular diagnosis system for neurological diseases based on DNAmicroarrays.
开发基于DNA微阵列的神经系统疾病综合分子诊断系统。
  • 批准号:
    18209032
  • 财政年份:
    2006
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Elucidation of molecular mechanisms of neurological diseases based on genome analysis
基于基因组分析阐明神经系统疾病的分子机制
  • 批准号:
    17019006
  • 财政年份:
    2005
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Development of DNA microarray-based reseqeuncing system for neurological diseases.
开发基于 DNA 微阵列的神经系统疾病重测序系统。
  • 批准号:
    16209028
  • 财政年份:
    2004
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Applied Genomics
应用基因组学
  • 批准号:
    16065101
  • 财政年份:
    2004
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Identified the causative gene for EAOH end elucidation the molecular mechanisms of neurodegeneration in EAOH
鉴定了EAOH的致病基因,阐明了EAOH神经变性的分子机制
  • 批准号:
    14207029
  • 财政年份:
    2002
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular mechanisms of neurodegeneration
神经退行性变的分子机制
  • 批准号:
    12210008
  • 财政年份:
    2000
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
The Study of the welfare needs and the treatment of old peoples in the metropolis
大城市老年人福利需求及待遇研究
  • 批准号:
    11610185
  • 财政年份:
    1999
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

DNA repair proteins as modifiers of CAG repeat instability in Huntington's disease
DNA 修复蛋白作为亨廷顿病中 CAG 重复不稳定性的修饰剂
  • 批准号:
    420949
  • 财政年份:
    2020
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Operating Grants
Investigating the effects of CAG repeat structure and MSH3 variants on the molecular biology of Huntington's disease
研究 CAG 重复结构和 MSH3 变异对亨廷顿舞蹈病分子生物学的影响
  • 批准号:
    MR/S006583/1
  • 财政年份:
    2018
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Research Grant
Development of curative therapy for polyglutamine disease by CAG repeat genome engineering
通过CAG重复基因组工程开发多聚谷氨酰胺疾病的治疗方法
  • 批准号:
    17K19465
  • 财政年份:
    2017
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Long-read sequencing the HTT CAG repeat
HTT CAG 重复序列的长读长测序
  • 批准号:
    1947177
  • 财政年份:
    2017
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Studentship
Myotonic Dystrophy and Congenital form: genetic and epigenetic marks associated with CTG/CAG repeat instability
强直性肌营养不良和先天性形式:与 CTG/CAG 重复不稳定相关的遗传和表观遗传标记
  • 批准号:
    351792
  • 财政年份:
    2016
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Operating Grants
Genome-Wide Screen for Clinically Relevant Modifiers of CAG Repeat Instability
全基因组筛选 CAG 重复不稳定性的临床相关修饰因子
  • 批准号:
    7754315
  • 财政年份:
    2009
  • 资助金额:
    $ 22.39万
  • 项目类别:
ANDROGEN RECEPTOR CAG REPEAT POLYMORPHISM & HYPOTHALAMIC SEX STEROID SENSITIVITY
雄激素受体 CAG 重复多态性
  • 批准号:
    7951468
  • 财政年份:
    2009
  • 资助金额:
    $ 22.39万
  • 项目类别:
ANDROGEN RECEPTOR CAG REPEAT POLYMORPHISM & HYPOTHALAMIC SEX STEROID SENSITIVITY
雄激素受体 CAG 重复多态性
  • 批准号:
    7718551
  • 财政年份:
    2008
  • 资助金额:
    $ 22.39万
  • 项目类别:
ANDROGEN RECEPTOR CAG REPEAT POLYMORPHISM AND SERUM ANDROGEN IN ADOLESCENT GIRLS
青春期女孩雄激素受体CAG重复多态性和血清雄激素
  • 批准号:
    7718557
  • 财政年份:
    2008
  • 资助金额:
    $ 22.39万
  • 项目类别:
ANDROGEN RECEPTOR CAG REPEAT POLYMORPHISM & HYPOTHALAMIC SEX STEROID SENSITIVITY
雄激素受体 CAG 重复多态性
  • 批准号:
    7606698
  • 财政年份:
    2007
  • 资助金额:
    $ 22.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了